Regents Of The University Of California Centessa Pharmaceuticals PLC Transaction History
Regents Of The University Of California
- $129 Million
- Q1 2025
A detailed history of Regents Of The University Of California transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Regents Of The University Of California holds 81,884 shares of CNTA stock, worth $1.04 Million. This represents 0.91% of its overall portfolio holdings.
Number of Shares
81,884Holding current value
$1.04 Million% of portfolio
0.91%Shares
1 transactions
Others Institutions Holding CNTA
# of Institutions
142Shares Held
124MCall Options Held
163KPut Options Held
816K-
Medicxi Ventures Management (Jersey) LTD20MShares$254 Million75.25% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$127 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$123 Million4.7% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.95MShares$88.6 Million0.19% of portfolio
-
Janus Henderson Group PLC London, X05.92MShares$75.5 Million0.05% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.2B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...